Status:
COMPLETED
Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
CSL Behring
University of Pennsylvania
Conditions:
Hemophilia A
Hemophilia B
Eligibility:
FEMALE
1+ years
Brief Summary
To collect and analyze data on females with hemophilia so as to better define the difference between the study population and the male population with hemophilia.
Detailed Description
This study is designed as an epidemiological study with retrospective clinical and genetic data collection and prospective quality of life (QOL) data collections and genotyping of subjects without cur...
Eligibility Criteria
Inclusion
- Females with severe (FVIII\<0.01u/dl) or moderate (FVIII-0.01\<0.06 u/dl) hemophilia A
- Females with severe (FIX\<0.01u/dl) or moderate (FIX-0.01\<0.06u/dl) hemophilia B
- Willingness to participate in the study.
Exclusion
- Subjects who do not meet the inclusion criteria with respect to gender or hemophilia severity.
Key Trial Info
Start Date :
April 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00936845
Start Date
April 1 2005
End Date
January 1 2010
Last Update
December 10 2012
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope National Medical Center
Duarte, California, United States, 91010
2
Mountain States Regional Hemophilia and Thrombosis Center
Aurora, Colorado, United States, 80045
3
Georgetown University Hospital
Washington D.C., District of Columbia, United States, 20007
4
Emory University Hemophilia Program Office
Atlanta, Georgia, United States, 30322